Hala Muhammed

  • Citations Per Year
Learn More
BACKGROUND Simeprevir plus sofosbuvir (SIM/SOF) regimen was recommended by professional guidelines for certain patients with HCV genotype 1 infection and there is lack of data about this regimen in patients with genotype 4 infection. AIM To evaluate the efficacy and safety of this regimen in Egyptian patients with chronic HCV genotype 4 infection in the(More)
  • 1